| 000 | 01582 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513144057.0 | ||
| 264 | 0 | _c19980819 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0924-8579 | ||
| 024 | 7 |
_a10.1016/s0924-8579(98)00010-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmori, M | |
| 245 | 0 | 0 |
_aEvaluation of in vivo therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, in SCID mouse model for disseminated Mycobacterium avium complex infection. _h[electronic resource] |
| 260 |
_bInternational journal of antimicrobial agents _cApr 1998 |
||
| 300 |
_a59-65 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xtherapeutic use |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aLung _xpathology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aMycobacterium avium Complex _xgrowth & development |
| 650 | 0 | 4 |
_aMycobacterium avium-intracellulare Infection _xmicrobiology |
| 650 | 0 | 4 |
_aRifamycins _xtherapeutic use |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
| 700 | 1 | _aTomioka, H | |
| 700 | 1 | _aSato, K | |
| 700 | 1 | _aSaito, H | |
| 773 | 0 |
_tInternational journal of antimicrobial agents _gvol. 10 _gno. 1 _gp. 59-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0924-8579(98)00010-7 _zAvailable from publisher's website |
| 999 |
_c9590941 _d9590941 |
||